Project description
Enhanced understanding of regulators of oocyte health could have broad implications
Despite tremendous advances in artificial reproductive technologies, rates of successful pregnancies and births remain low in both human and animal populations. Treatments can be expensive and insurance coverage is limited, potentially negating a person’s ability to undergo treatment or limiting the number of treatments one can afford. Enhancing success rates could have important societal and economic impact, helping more people get pregnant with less emotional and economic burden and supporting the preservation of endangered species with artificial reproduction. EUROVA plans to increase understanding of the mechanisms regulating oocyte health, fertilisation and zygote transition while training young researchers in oocyte biology. Identifying checkpoints and regulators may help in reprogramming the cell cycle for greater success.
Fields of science
- social scienceseconomics and businesseconomicsproduction economicsproductivity
- medical and health sciencesclinical medicineobstetrics
- agricultural sciencesanimal and dairy sciencedomestic animalsanimal husbandry
- natural sciencesbiological sciencesgeneticsheredity
- medical and health sciencesbasic medicinetoxicology
Programme(s)
Coordinator
4 Dublin
Ireland
See on map
Participants (10)
20122 Milano
See on map
1050 Brussel
See on map
CB22 3AT Cambridge
See on map
08029 Barcelona
See on map
9000 Gent
See on map
28006 Madrid
See on map
Participation ended
93100 Montreuil
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
12489 Berlin
See on map
3400 Hillerod
See on map
Participation ended
75011 Paris
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.